<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR154">
 <label>154.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Machado</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Torres</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <article-title>Guselkumab for the Treatment of Psoriasis</article-title>
  <source>Biodrugs.</source>
  <year>2018</year>
  <volume>32</volume>
  <fpage>119</fpage>
  <lpage>128</lpage>
  <pub-id pub-id-type="doi">10.1007/s40259-018-0265-6</pub-id>
  <?supplied-pmid 29470778?>
  <pub-id pub-id-type="pmid">29470778</pub-id>
 </element-citation>
</ref>
